Integra Biosciences Corporation – Trademark Portfolio

Entity Type: 03

Integra Biosciences Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VIAPURE and VIAPURE CERTIFIED DNASE, RNASE, PYROGEN, PCR INHIBITOR, ENDOTOXIN FREE. The owner is based in Hudson, NH.

2 Wentworth Drive

Hudson, NH 03051

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Integra Biosciences Corporation's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Integra Biosciences Corporation have?

Integra Biosciences Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Integra Biosciences Corporation file in?

Integra Biosciences Corporation files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Integra Biosciences Corporation's most well-known trademarks?

Integra Biosciences Corporation's registered trademark portfolio includes well-known marks such as VIAPURE and VIAPURE CERTIFIED DNASE, RNASE, PYROGEN, PCR INHIBITOR, ENDOTOXIN FREE. These are among 2 currently registered trademarks in the portfolio.

What is Integra Biosciences Corporation's trademark registration success rate?

Integra Biosciences Corporation has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.